Examining yoga as a complementary therapy for anxiety and depressio
- Conditions
- Anxiety disordersDepressive disordersMental Health - AnxietyMental Health - Depression
- Registration Number
- ACTRN12620000601932
- Lead Sponsor
- Deakin University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 50
Diagnosis of anxiety or depression of mild to moderate severity, based on the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), established via Clinical Interview based on the Structured Clinical Interview (SCID) for DSM-5 (American Psychological Association (APA), 2013).
-English speaking.
-Capacity to provide informed consent.
Based on the clinic exclusion criteria for participating in a group program, individuals will not be eligible to participate in the trial if they are:
-Deemed to have a high risk of harming self or others.
-Deemed unsuitable for group treatment at the time (e.g. presentation is too complex, or individual may not benefit due to personality style etc.). Screening procedures used by the clinic identify such individuals.
-Not available to participate in the group programs at the allocated times.
-Experiencing a significant medical comorbidity, cognitive impairment, or substance dependence.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinically significant change will be assessed based on the totals scores of the Depression Anxiety Stress Scale - 21 items (DASS-21)* (Lovibond & Lovibond, 1995). The DASS-21 is a self-report measure that consists of three scales designed to assess the emotional states of depression, anxiety and stress. Each of the three scales contains seven items that are scored from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time). Scores are calculated for each subscale, with the total score calculated by summing each subscale multiplied by two. The scale is reported to have high internal consistency (Cronbach’s alpha = .92) and re-test reliability (r = .91) (Lovibond & Lovibond, 1995).[Pre-intervention/baseline<br>Post-intervention (8 weeks) (Primary timepoint)<br>Three-months post-intervention<br>12-months post-intervention]
- Secondary Outcome Measures
Name Time Method